Similarly, CRC with low USP21 displayed heightened sensitivity to traditional chemotherapy, including alkylating agents such as cisplatin, Vinblastine, antibiotics like bleomycin, and antimetabolites such as gemcitabine (Fig. 7C). Here, USP21 is linked to colorectal carcinoma.